The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
Background: There is conflicting data about the increased risk of pulmonary toxicity when granulocyte-stimulating factor (G-CSF) is given in combination with bleomycin. No clear consensus for management of patients with Hodgkin lymphoma (HL) who require G-CSF support exists. Our objective was to eva...
| Published in: | International Journal of Hematology-Oncology and Stem Cell Research |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2017-10-01
|
| Subjects: | |
| Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/776 |